Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published in 2012

There are 85 items in the Healthy Skepticism Library that were published in 2012.

Page 1 of 1 pages

Roehr B
Eli Lilly settles corrupt foreign practices complaint for $29.4m
BMJ 2012 Dec 27; 345:e8694

Sinha K
Govt to crack down on pharma-doctor nexus
Times of India 2012 Dec 26

Rodwin MA
Independent Clinical Trials to Test Drugs: The Neglected Reform
Saint Louis University Journal of Health Law & Policy 2012 Dec 24; 6:(12-58):113

Ray K
Doc’s plaint stops vaccine ad on TV
The Deccan Herald 2012 Dec 14

Boumil MM
Off-Label Marketing and the First Amendment
NEJM 2012 Dec 12; 368:103-105

Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L
Industry sponsorship and research outcome
The Cochrane Library 2012 Dec 12; (12):

Segatto C
O real risco das novas pílulas
Época 2012 Dec 9

Hegde BM
Money is Mammon in pharmaceutical world
The Hindu 2012 Dec 9

AstraZeneca’s cancer drug patent rejected
The Deccan Herald 2012 Nov 28

Medicines for needy
The Deccan Herald 2012 Nov 28

Kumar C
Govt pact with generic drug seller ‘illegal’
The Deccan Herald 2012 Nov 28

Swan N
The High Costs of Pharmaceuticals in Australia
Health Report : Radio National 2012 Nov 260

Srinivasan S
Is the shift away from cost-plus drug pricing desirable? - NO
The Hindu Business Line 2012 Nov 23

Shah DG
Is the shift away from cost-plus drug pricing desirable? - YES
The Hindu Business Line 2012 Nov 23

Ferner R
A short history of pharmaceutical marketing
BMJ 2012 Nov 20; 345:e7801

Karmali N
India's Pharma Kings Are The Country's Big Winners
Forbes 2012 Oct 25

Devinney T
Integrity pays dividends: the case for minding your own business
The Conversation 2012 Oct 25

Preston C, Valdez M, Bond K
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
PLoS Med 2012 Oct 23; 9:(10):

Joelving F
Exclusive: Abbott suspends giving gifts to doctors in India
Reuters 2012 Oct 16

Lewis H
Lies, damn lies and drug trials
New Statesman 2012 Oct 4

Supreme Court asks Centre not to alter pricing system for essential drugs
The Economic Times 2012 Oct 3

Reynolds M
Australian Pharma companies bow to demanding doctors 2012 Oct 2

Thomas C
Medical journals: 'information-laundering for Big Pharma'?
The Ethical Nag 2012 Sep 26

Luthra S
U. forgoes action against prof after study fraud
The Brown Daily Herald 2012 Sep 14

Bates A
How to Get More Sales from Your Sales Force Efforts
eyeforpharma 2012 Sep 4

Djulbegovic B, Hozo I, Beckstead J, Tsalatsanis A, Pauker SG
Dual processing model of medical decision-making
BMC Medical Informatics and Decision Making 2012 Sep 3; 12:(94):

Lee M, Hirschler B
China's 'wild east' drug store
Reuters 2012 Aug 28

Light DW, Lexchin JR
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012 Aug 11;

Harvey K
TGA failure gives Nurofen consumers a headache
The Conversation 2012 Aug 10

Bita N
Pharmaceutical companies spends $30m wining, dining doctors
The Australian 2012 Aug 10

Unnikrishnan C
Doctors' freebies to be taxed
Times of India 2012 Aug 7

Kesselheim AS, Wang B, Studdert DM, Avorn J
Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
PLoS Med 2012 Aug 7; 9:(8):

Jones MI
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2012 Aug 4; 323:1-7

Barker A
EU to charge two drugmakers over generics
The Financial Times 2012 July 25

Fisher JA, Kalbaugh CA
United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
PLoS Med 2012 July 24; 9:(7):

Saying 'no thanks' to the pharmaceutical industry's undue influence
Prescrire 2012 July 23;

Sharma H
Pharma firms funding foreign trips for doctors
IBN Live 2012 July 18

ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
HAI Europe 2012 July 16

‘Sponsored’ doctors under scanner
The New Indian Express 2012 July 11

Glekin J
India's pro-poor policy may be getting healthier
Reuters Breakingviews 2012 July 5

Glaxo to pay $3 bn for largest health fraud in US
The Washington Post 2012 July 3

GlaxoSmithKline to pay $3bn in US drug fraud scandal
BBC News 2012 July 2

Karlin M
Big Pharma Drug Company Gets Fined 3 Billion Dollars for Marketing Abuse of Drugs, But No Criminal Charges
The Buzzflash Blog 2012 July 2

Ray K
Drug companies fleecing consumers: Study
The Deccan Herald 2012 Jun 15

Kaplan WA, Ritz LS, Vitello M, Wirtz VJ
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy 2012 Jun 13;

Weissman R, So A
Generating Antibiotic Incentives Now: GAIN Or Just Greed
Citizen Vox 2012 Jun 12

Dabade G
When drug regulators play with people’s lives
The Deccan Herald 2012 May 22

Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1; 344:

Big Pharma spends over €40 million per year lobbying in the EU, dwarfing public health NGOs
HAI Europe 2012 Mar 28

Silverman E
Pharma Execs Admit: ‘Our Model Is Broken’
Pharmalot 2012 Mar 21

Dunlevy S
Australian Big Pharma to derail gravy train Ken Harvey
The Australian 2012 Mar 19

O'Brien M
'Unethical': NHMRC to reveal stance on homeopathy
Medical Observer 2012 Mar 14

Bajaj V, Pollack A
If Novartis wins, prices of drugs could sky-rocket
The Deccan Herald 2012 Mar 8

Reid-Henry S
Novartis vs India: the showdown approaches
New Internationalist Blog 2012 Feb 28

Metherell M
Hunt for the truth behind diet pill
The Sydney Morning Herald 2012 Feb 18

Baloch F
Spurious drugs case: Pharma association’s acting chief blasts industry, regulator
The Express Tribune 2012 Feb 17

Imprensa RP
Anvisa não pode mais vetar publicidade de medicamentos, diz Justiça
Portal Imprensa 2012 Feb 3

Pickett FA
Misrepresentation of Scientific Studies Misleads Professional Caregivers
Dentition 2012 Feb; 1:(1):14-19

Brody H
Opinion: Celebrities Pushing Drugs?
The Scientist 2012 Jan 30

Cohen D
Deborah Cohen: Roche responds
BMJ Group Blogs 2012 Jan 27

Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24; 9:(1):

Key Opinion Leaders Who Lend Their Names to Ghostwritten Medical Articles Should Be Held Legally Liable, Article States
Baum, Hedlund, Aristei & Goldman 2012 Jan 24

Collins G
Call to axe starter packs
6minutes 2012 Jan 23

Alexander J
Health ministry asks state drug controllers to closely monitor misleading ads on vitamins, creams
Pharmabiz 2012 Jan 18

Laurance J
Implant danger extends to all medical devices
The Independent 2012 Jan 18

Pear R
U.S. to Force Drug Firms to Report Money Paid to Doctors
The New York Times 2012 Jan 16

Dabade G
With 100% FDI in pharma, medicines may soon cost more
The Deccan Herald 2012 Jan 15

Khor M
TWN Info Service on Intellectual Property Issues
Third World Network 2012 Jan 14

Voreacos D, Cronin Fisk M, Feeley J
J&J Marketed Risperdal for Kids After FDA Warnings, Jurors Told
Bloomberg 2012 Jan 14

Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10; 344:

Christensen M, Knop FK
The unobtainable placebo: control of independent clinical research by industry?
The Lancet 2012 Jan 7; 379:(9810):30

Shankar PR, Singh KK, Piryani RM
Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school
BMC Research Notes 2012 Jan 6; 5:(8):

Fiddamen B
APA Use Restraints on Blogger
Seroxat Sufferers: Stand Up and Be Counted 2012 Jan 4

Lehman R, Loder E
Missing clinical trial data
BMJ 2012 Jan 3; 344:

Cardenal Taján J
GSK fined after over vaccine trials; 14 babies reported dead
Buenos Aires Herald 2012 Jan 3

Moynihan R
Kissing goodbye to key opinion leaders
Medical Journal of Australia 2012; 196:(11):671

Lexchin J, Vitry A
Should the C in CME Stand for Commercial?
Southern Med Review 2012; 5:(1):3-5

Grills NJ
The ethics of industry sponsorship of charities
MJA 2012; 197:(3):139

Wolfe SM
The seven-year rule for safer prescribing
Aust Prescr 2012; 35:(5):138-9

Puliyel J
Compensation for Victims of Clinical Trials: A Discussion on How Current Indian Rules and Guidelines are Hurting India
Journal of Clinical and Diagnositic Research 2012;

McNamara S
Antidepressant research divides experts
MJA Insight 2012 03 12; (9):

Phillips & Cohen
Whistleblower ('qui tam') lawsuit against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012

Phillips & Cohen
Glaxo’s settlement agreement and the government’s charges against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012

Harvey K
Pfizer Includes Foreign Corrupt Practices Act Violations in Its Arsenal of Illegal Activities
Worst Pills, Best Pills 2012 Sep

Boldrin M, Levine DK
The Case Against Patents
Federal Reserve Bank of St Louis 2012

Page 1 of 1 pages


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909